VELDONA® interferon-alpha formulation has shown potential as a treatment candidate for feline chronic gingivostomatitis and canine atopic dermatitis
Ainos advances its product pipeline as it targets commencing clinical studies during the second quarter of 2023
Read more at prnewswire.com